Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial

Author:

Fong Youyi,McDermott Adrian B.ORCID,Benkeser DavidORCID,Roels Sanne,Stieh Daniel J.,Vandebosch An,Le Gars Mathieu,Van Roey Griet A.,Houchens Christopher R.,Martins Karen,Jayashankar Lakshmi,Castellino Flora,Amoa-Awua Obrimpong,Basappa Manjula,Flach Britta,Lin Bob C.,Moore Christopher,Naisan Mursal,Naqvi Muhammed,Narpala Sandeep,O’Connell Sarah,Mueller Allen,Serebryannyy Leo,Castro MikeORCID,Wang Jennifer,Petropoulos Christos J.ORCID,Luedtke Alex,Hyrien Ollivier,Lu Yiwen,Yu Chenchen,Borate Bhavesh,van der Laan Lars W. P.,Hejazi Nima S.ORCID,Kenny Avi,Carone MarcoORCID,Wolfe Daniel N.,Sadoff Jerald,Gray Glenda E.,Grinsztejn Beatriz,Goepfert Paul A.,Little Susan J.,Paiva de Sousa LeonardoORCID,Maboa Rebone,Randhawa April K.ORCID,Andrasik Michele P.,Hendriks Jenny,Truyers Carla,Struyf FrankORCID,Schuitemaker HannekeORCID,Douoguih MacayaORCID,Kublin James G.,Corey LawrenceORCID,Neuzil Kathleen M.ORCID,Carpp Lindsay N.ORCID,Follmann DeanORCID,Gilbert Peter B.ORCID,Koup Richard A.,Donis Ruben O., , ,

Funder

U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Microbiology (medical),Genetics,Applied Microbiology and Biotechnology,Immunology,Microbiology

Reference46 articles.

1. Sadoff, J. et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N. Engl. J. Med. 384, 2187–2201 (2021).

2. Sadoff, J. et al. Final analysis of efficacy and safety of single-dose Ad26.COV2.S. N. Engl. J. Med. 386, 847–860 (2022).

3. Janssen COVID-19 Vaccine (US Food and Drug Administration, accessed 23 January 2022); https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/janssen-covid-19-vaccine

4. COVID-19 Vaccines WHO EUL Issued (World Health Organization, accessed 24 January, 2022); https://extranet.who.int/pqweb/vaccines/vaccinescovid-19-vaccine-eul-issued

5. European Commission Authorises Fourth Safe and Effective Vaccine Against COVID-19 (European Commission, accessed 24 January 2022); https://ec.europa.eu/commission/presscorner/detail/en/ip_21_1085

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3